Amgen lowers cholesterol drug Repatha cost 60% amid political talk of high drug prices

The pharmaceutical company Amgen announced Wednesday that it will decrease the price of its cholesterol lowe...

Posted: Oct 25, 2018 4:22 AM
Updated: Oct 25, 2018 4:22 AM

The pharmaceutical company Amgen announced Wednesday that it will decrease the price of its cholesterol lowering drug Repatha by 60%. The company said some patients weren't filling their prescriptions because the cost was too high.

Even with a coupon, if you were to fill the prescription for a single cartridge the average price was around $1,435 according to data from prescription website GoodRx Wednesday morning before the company announcement. Patients likely have to take it indefinitely, and insurers don't always cover it.

Amgen Inc

Business and industry sectors

Business, economy and trade

Cholesterol

Companies

Diet and nutrition

Diet, nutrition and fitness

Donald Trump

Drug prices

Health and medical

Health care

Health care costs

Pfizer Inc

Pharmaceutical industry

Pharmaceuticals and biotechnology

Pharmaceuticals and prescription drugs

Political Figures - US

Nutrition

The antibody drug is for patients with a genetic condition that causes high LDL cholesterol levels and people who have already had a heart attack or stroke or who can't get cholesterol levels down even with lifestyle changes.

The drug works by reducing LDL cholesterol that can build up in your artery walls. When it builds up, it blocks an enzyme known as PCSK9. The enzyme helps your liver receptors clear LDL cholesterol out of your body. In drug trials the company submitted for approval to the United States Food and Drug Administration and in subsequent studies, Repatha was shown to significantly lower LDL cholesterol in patients. It lowered LDL by 60% in patients that were already taking statins, according to a 2017 study. The FDA approved the drug in 2015.

Heart disease and stroke often are preventable, yet they remain the leading cause of disability, death and health care spending in the US according to the Centers for Disease Control and Prevention.

The company said it is lowering the price because it found 70% of patients were abandoning their prescription for the product because of its price.

"Our top priority is getting the drugs to our patients and the price just wasn't working," said Dr. Steven K. Galson, senior vice president, global regulatory affairs and safety at Amgen. Galson said they heard stories about patients going to the pharmacy and being told their copay would be almost $400 a month "and they turn around and leave without the drug."

In a call with reporters Wednesday, the company said Medicare patients will see a particular benefit. For instance, instead of paying between $200 and more than $300 a month out of pocket patients will instead pay more in the range of $25 to $150 a month out of pocket. No specifics were given on what the cost will be for patients with private insurance.

"Anytime anyone takes a step toward price transparency and lowering the costs of drugs [it] is a good thing," said Doug Hirsch the GoodRx Co-founder/Co-CEO. "I still think it will be too expensive for most Americans."

Hirsch said looking through the data they keep on drugs, very few people have filled a prescription for Repatha and unless more insurance companies start to cover the drug, he doesn't think that many more people will use it, especially since there are alternative options out there that, even with the price cut, cost a lot less. He doesn't see the move encouraging other companies to do the same with their drugs.

Amgen's cost cutting move comes amid the broader political conversation about how to fix the high price of drugs. Per capita prescription drug spending in the US exceeds that in all other countries, studies show. The amount Americans spend on drugs has nearly doubled since the 1990s, a 2017 government investigation found.

In October, President Donald Trump signed two bills into law that were meant to help patients know more about how much their drugs cost. At the signing ceremony, the President said the American people can expect further regulatory action to reduce drug prices in the coming months. In January 2017, Trump accused the pharmaceutical industry of "getting away with murder" with the high prices they charge for drugs.

In July, the Swiss company Novartis promised that it wouldn't raise prices for US customers this year. It's rival Pfizer made a similar promise that month. That announcement came after Trump met with the Pfizer CEO and tweeeted his praise saying, "Pfizer is rolling back price hikes, so American patients don't pay more. We applaud Pfizer for this decision and hope other companies do the same."

Drug companies have made similar overall cost containment promises in the past. There was a flurry of such press releases in the 1990s, but drug prices continued to rise.

Galson said this is the first time Amgen has lowered the price of an individual drug that is already on the market in this manner. "Of course we are feeling the heat, everyone is, but we feel the heat internally, even without [general pressure from] the President," said Galson. "If you have 70% of patients abandoning the product due to price it is just horrible."

Huntsville
Clear
47° wxIcon
Hi: 57° Lo: 34°
Feels Like: 42°
Florence
Clear
46° wxIcon
Hi: 59° Lo: 36°
Feels Like: 42°
Fayetteville
Clear
45° wxIcon
Hi: 55° Lo: 33°
Feels Like: 42°
Decatur
Clear
45° wxIcon
Hi: 57° Lo: 33°
Feels Like: 38°
Scottsboro
Clear
48° wxIcon
Hi: 58° Lo: 35°
Feels Like: 45°
WAAY Radar
WAAY WAAY-TV Cam
WAAY Temperatures

Alabama Coronavirus Cases

Cases: 232506

Reported Deaths: 3457
CountyCasesDeaths
Jefferson30318491
Mobile19260356
Tuscaloosa12446148
Madison12204146
Montgomery12000232
Shelby971276
Baldwin819984
Lee750464
Morgan610447
Calhoun5964113
Etowah585764
Marshall579453
Houston503338
DeKalb460835
Cullman409636
Limestone400844
St. Clair396055
Elmore391061
Lauderdale378353
Walker348096
Talladega334042
Colbert294341
Jackson290524
Blount275436
Autauga261739
Franklin243633
Coffee230315
Dale225454
Dallas219631
Russell21753
Chilton216137
Covington212333
Escambia194031
Tallapoosa168590
Chambers167548
Clarke154919
Pike154714
Marion133935
Winston122523
Lawrence121436
Geneva11678
Marengo116424
Barbour116010
Pickens114118
Bibb113617
Butler113341
Randolph99521
Cherokee98524
Hale91531
Washington89818
Clay88823
Henry8386
Fayette83116
Lowndes78529
Monroe76811
Cleburne74214
Crenshaw70030
Macon69420
Bullock68919
Conecuh66814
Perry6686
Wilcox62318
Lamar6227
Sumter55322
Choctaw41713
Greene39917
Coosa3064
Out of AL00
Unassigned00

Tennessee Coronavirus Cases

Cases: 340476

Reported Deaths: 4266
CountyCasesDeaths
Shelby45436634
Davidson40436402
Knox17413137
Rutherford16668150
Hamilton15723135
Williamson1050373
Sumner9016134
Wilson692474
Out of TN668748
Montgomery614481
Sullivan594689
Putnam572279
Washington550298
Maury541957
Blount508055
Madison5064104
Bradley476833
Sevier458530
Unassigned416314
Robertson352550
Tipton345136
Hamblen328257
Dyer307149
Gibson297761
Greene281868
Anderson271525
Dickson264427
Coffee260841
Carter250951
Bedford250328
Obion250347
Lawrence249632
Cumberland240035
McMinn232255
Warren226517
Hardeman220337
Roane217723
Loudon216517
Jefferson212631
Fayette212137
Weakley205934
Lauderdale198721
Monroe197042
Franklin189631
Trousdale189012
Wayne179310
Hawkins178234
Henderson178030
Macon175727
Hardin170925
White166417
Marshall163117
Carroll162832
Haywood159129
Rhea155530
Cocke153928
Overton150034
Campbell146521
Cheatham146316
Lincoln144413
Henry141517
McNairy137232
Smith136919
Johnson136721
Giles134242
Fentress116219
Lake11445
Bledsoe11405
Crockett110925
Hickman109417
DeKalb108220
Marion103117
Chester97919
Scott9407
Grainger91314
Decatur91012
Unicoi77123
Claiborne7509
Benton74914
Grundy73414
Lewis70411
Cannon6962
Union6865
Jackson6579
Morgan6546
Humphreys6407
Polk62914
Houston56819
Stewart54614
Clay52418
Sequatchie4895
Meigs45912
Perry45520
Moore3652
Pickett36512
Van Buren3382
Hancock1453

Community Events